Notice

The database server is currently not answering requests properly. Some pages are still available due to caching. We are investigating the situation and will keep you updated.

Astellas Pharma Inc.
アステラス製薬株式会社

Japan

1 July 2019 - 30 June 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Astellas Pharma Inc. published between 1 July 2019 - 30 June 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
4 0.02

Outputs by subject (Share)

Subject Count Share
Chemistry 2 0.01
Life Sciences 3 0.01
1 0.01
2 0
Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
2019-08-01
0
Conformational landscape alternations promote oncogenic activities of Ras-related C3 botulinum toxin substrate 1 as revealed by NMR
2019-03-01
0
Physical Sciences 1 0.01

Return to institution outputs